Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (261-270 of 308) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2008
A role for the host coatomer and KDEL receptor in early vaccinia biogenesisLeiliang Zhang, Stella Y Lee, Galina V Beznoussenko, et al.
Journal of Virology|May 22, 2002
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infectionSampa Santra, Dan H Barouch, Marcelo J Kuroda, et al.
Virology|May 27, 2006
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challengesDennis Ellenberger, Ronald A Otten, Bin Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIVKoen K A Van Rompay, Kristina Abel, Jonathan R Lawson, et al.
AIDS Research and Human Retroviruses|February 24, 2005
Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responsesJames M Smith, Rama Rao Amara, Linda S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2006
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virusZhaochun Chen, Patricia Earl, Jeffrey Americo, et al.
Vaccine|December 10, 2009
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIVKoen K A Van Rompay, Kristina Abel, Patricia Earl, et al.
Plos One|April 16, 2015
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adultsAgricola Joachim, Charlotta Nilsson, Said Aboud, et al.
Nature Communications|February 20, 2019
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challengeAndrew T Jones, Xiaoying Shen, Korey L Walter, et al.
Journal of Virology|July 5, 2002
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccinesRama Rao Amara, Francois Villinger, Silvija I Staprans, et al.
Pageof 31

Showing results (261-270 of 308) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2008
A role for the host coatomer and KDEL receptor in early vaccinia biogenesisLeiliang Zhang, Stella Y Lee, Galina V Beznoussenko, et al.
Journal of Virology|May 22, 2002
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infectionSampa Santra, Dan H Barouch, Marcelo J Kuroda, et al.
Virology|May 27, 2006
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challengesDennis Ellenberger, Ronald A Otten, Bin Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIVKoen K A Van Rompay, Kristina Abel, Jonathan R Lawson, et al.
AIDS Research and Human Retroviruses|February 24, 2005
Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responsesJames M Smith, Rama Rao Amara, Linda S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2006
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virusZhaochun Chen, Patricia Earl, Jeffrey Americo, et al.
Vaccine|December 10, 2009
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIVKoen K A Van Rompay, Kristina Abel, Patricia Earl, et al.
Plos One|April 16, 2015
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adultsAgricola Joachim, Charlotta Nilsson, Said Aboud, et al.
Nature Communications|February 20, 2019
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challengeAndrew T Jones, Xiaoying Shen, Korey L Walter, et al.
Journal of Virology|July 5, 2002
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccinesRama Rao Amara, Francois Villinger, Silvija I Staprans, et al.
Pageof 31